A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up

Wu, Gang; Hong, Zhe; Li, Chao; Bian, Cuidong; Huang, Shengsong; Wu, Denglong

doi:10.1007/s10103-016-1883-1

Cited by 39 publications

(23 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the RCT performed by Wu et al (), the occurrence rate between DiLEP and BipoLEP was not statistically significant with respect to retrograde ejaculation (30.0% vs. 15.0%, p = .11). Zou et al () also reported a similar incidence of retrograde ejaculation between DiLEP and BipoLEP (45.6% vs. 33.3%, p = .180).…”

Section: Evidence Synthesismentioning

confidence: 84%

Complications of anatomical endoscopic enucleation of the prostate

Wei

et al. 2020

Andrologia

View full text Add to dashboard Cite

Transurethral resection of the prostate (TURP) remains the 'gold standard' for surgical treatment of benign prostatic obstruction (BPO). Recently, anatomical endoscopic enucleation of the prostate (AEEP) using holmium laser, thulium laser and plasma, etc., is extensively applied in clinical practice. However, perioperative complications of AEEP are inevitable in spite of lower incidence compared with TURP. This study reviewed the literature related to the aetiology, prevention and treatment of common complications of AEEP, which would contribute to the diagnosis and treatment of BPO.

show abstract

Section: Evidence Synthesismentioning

confidence: 84%

Complications of anatomical endoscopic enucleation of the prostate

Wei

et al. 2020

Andrologia

View full text Add to dashboard Cite

show abstract

“…One RCT comparing the 12‐month clinical outcome of ThuLEP versus BipolEP revealed an equal improvement in IPSS, QoL, Qmax and PVR, while ThuLEP was associated with less risk of haemorrhage and shorter catheter time, although the difference was of little clinical relevance (Feng, Zhang, Tian, & Song, 2016). There have been three RCT comparing the efficacy of DiLEP versus BipolEP, all revealed equal efficacy in IPSS, Qmax, PVR and QoL at 12 months (Wu et al., 2016; Xu et al., 2013; Zou et al., 2018), while two studies demonstrated that DiLEP was associated with less bleeding and shorter catheter time (Wu et al., 2016; Xu et al., 2013), but the other showed no difference in these perioperative parameters (Zou et al., 2018). Taken together, currently available evidences consistently demonstrated all these energy devices (holmium, thulium, diode and bipolar) achieved equivalent improvements in IPSS, Qmax, PVR and QoL.…”

Section: Discussionmentioning

confidence: 99%

Surgical outcome of anatomical endoscopic enucleation of the prostate: A systemic review and meta‐analysis

et al. 2020

View full text Add to dashboard Cite

Benign prostatic hyperplasia (BPH) is the most common aetiology of bladder outlet obstruction and lower urinary tract symptoms (LUTS) in men. While medical treatment is considered as the first-line treatment for male LUTS secondary to BPH, a substantial portion of men would require surgical intervention because of insufficient relief of LUTS with medications or having any absolute indication for surgery, such as recurrent or refractory urinary retention, recurrent urinary tract infections, bladder stones or diverticula, or dilatation of the upper urinary tract due to BPH, with or without renal insufficiency (Foster et al., 2019; Oelke et al., 2013). By removing the hyperplastic prostate tissue, the surgery can restore normal urine flow, relieve the LUTS, and avoid bladder dysfunction and damages to the upper urinary tract. Transurethral resection of prostate (TURP) and open prostatectomy (OP) have been traditionally considered as the gold standard of the surgical management for BPH (Foster et al., 2019; Oelke et al., 2013). TURP is currently the most common surgical modality for BPH with a medium to large prostate. It is generally effective in relieving the outlet obstruction. However, in TURP the prostate is resected in a piece-by-piece fashion, and bleeding may arise from any cutting. This usually requires repeated coagulation and is time-consuming. These facts significantly limit the efficiency of TURP and therefore usually prohibits a complete resection, especially in cases with a huge prostate. On the other hand, OP can simply achieve complete removal

show abstract

“…DiLEP is advantageous in that it provides markedly reduced blood loss, reduced hospital stay, and decreased catheter indwelling time. 21,22…”

Section: Discussionmentioning

confidence: 99%

1470 nm Diode Laser Enucleation vs Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Study

Zhang

Wang

Zhang

et al. 2019

Journal of Endourology

View full text Add to dashboard Cite

Objective: The purpose of the current work was to comparatively assess 1470 nm diode laser enucleation of the prostate (DiLEP) and plasmakinetic resection of the prostate (PKRP) for treating benign prostatic hyperplasia (BPH). Patients and Methods: From January 2016 to March 2017, 157 individuals with bladder outflow obstruction caused by BPH were randomized to DiLEP and PKRP groups, for prospective analysis. Of these, 152 cases were evaluated before operation and at 3, 6, and 12 months postsurgery. Patient baseline properties, presurgery data, and postsurgical outcomes were comparatively assessed, as well as complications. Results: There were no significant preoperative differences between surgical groups. DiLEP-treated cases showed remarkable reduced operative time, postsurgical bladder irrigation time, catheterization duration, and hospital stay compared with the PKRP group ( P < 0.001). Hemoglobin amount decrease was markedly less pronounced after DiLEP ( P = 0.004). However, no patients needed blood transfusion in either group. The decrease in sodium level showed no marked differences between the DiLEP and PKRP groups ( P = 0.380). In addition, complications were comparable and no significant differences in both groups. At 3, 6, and 12 months, International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Qmax), and postvoid residual (PVR) were similar in both groups ( P > 0.05). Conclusions: DiLEP and PKRP are similar in efficacy and safety for relieving obstruction and low urinary tract symptoms. Compared with PKRP, DiLEP has decreased risk of hemorrhage, operative time, bladder irrigation time, catheterization duration, and hospital stay. However, IPSS, QoL, Qmax, and PVR were similar for both procedures within 12 postoperative months.

show abstract

A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up

Cited by 39 publications

References 25 publications

Complications of anatomical endoscopic enucleation of the prostate

Complications of anatomical endoscopic enucleation of the prostate

Surgical outcome of anatomical endoscopic enucleation of the prostate: A systemic review and meta‐analysis

1470 nm Diode Laser Enucleation vs Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Study

Contact Info

Product

Resources

About